CAR-T Cell Therapy Resource Center
News & Information for Healthcare Professionals
Targeting immune cells that help tumors stay hidden could improve immunotherapy
June 20, 2017 (Medical News Today)
Immunotherapy drugs continue to only be effective in about 10 to 30 percent of cancer patients with certain...
New Immune Tx Achieves Remission in B-Cell Malignancies
February 16, 2016 (HealthDay News)
Patient’s T cells are engineered with chimeric antigen receptors
A new T-cell immunotherapy has led to sustained regression in many...
StatPearls Question of the Week – #8
Which condition has not been shown to respond to chimeric antigen receptor-engineered T cells (CAR-T cells) therapy?
A. Non-Hodgkin lymphoma
B. Acute lymphoblastic leukemia
C. Chronic...
ASCO: CAR T-Cell Therapy Promising in Multiple Myeloma
June 6, 2017 (HealthDay News)
Findings from trial of chimeric antigen receptor T cells targeting B-cell maturation protein
A new type of immunotherapy appears to...
VIDEO: Long and deep responses to CAR T-cell therapies in multiple myeloma
June 25, 2017 (VJHemOnc)
CAR T-cells seem to be taking the hematology world by storm. Here. Rakesh Popat, MD, PhD from the University College London,...
“Immunoswitch” particles may be key to more-effective cancer immunotherapy
June 12, 2017 (Medical News Today)
A nanoparticle has been created by scientists at Johns Hopkins, supporting two unique antibodies that may have the...
StatPearls Question of the Week – #7
So far in the early clinical trials, chimeric antigen receptor-engineered T cells (CAR-T cells) have targeted which receptor in the treatment of acute lymphoblastic...
VIDEO: CAR-T Therapy – How does it work?
February 28, 2017 (Kite Pharma)
See how CAR-T Therapy Works in this video from Kite Pharma.
CAR T-Cell Therapy HCP Guide – Side Effects: Tumor Lysis Syndrome
Tumor lysis syndrome (TLS) is another known and expected side effect of CAR T-cell therapy. TLS occurs due to cell death and sunsequent release...
CAR T-Cell Therapy HCP Guide – Side Effects: B Cell Aplasia
One of the advantages of CAR T-cell therapy that targets the C19 tumor antigen is that C19 is not found on other cells except...
